C: Pcdh-Shbmi-1 Suppressed Bmi-1 Mrna Expression in CD4+ T from ITP Patients (P=0.001)

C: Pcdh-Shbmi-1 Suppressed Bmi-1 Mrna Expression in CD4+ T from ITP Patients (P=0.001)

<p>Figure 1.Transfected and infected of lentiviral vectors were observed and the effect of lentiviral vectors infection.</p><p>A: The lentiviral vectors of pCDH-shBmi-1 and pCDH-Bmi-1 with expressing GFP in 293T were observed with fluorescence microscopy. </p><p>B: pCDH-shBmi-1 and pCDH-Bmi-1 infected with in CD4+ T cell expressing GFP were observed with fluorescence microscopy. </p><p>C: pCDH-shBmi-1 suppressed Bmi-1 mRNA expression in CD4+ T from ITP patients (p=0.001). </p><p>D: pCDH-Bmi-1 promoted Bmi-1 mRNA expression in CD4+ T from ITP patients significantly</p><p>(p=0.005).</p><p>E: pCDH-Bmi-1 suppressed shBmi-1 protein expression in 293T significantly. </p><p>Bars represent SD, * represents P <0.05. Figure 2 Representative flow cytometry scatter plot of PE-BrdU positive CD4+ T cells from ITP patient and healthy control. Table 1. Clinical parameters of ITP patients </p><p>Patients Sex Age(years) PLT(109/L) Therapy * P1 F 43 14 Pred P2 F 20 25 Pred IVIG P3 M 48 24 Pred P4 M 41 5 Pred P5 F 23 25 IVIG P6 M 18 23 None P7 M 16 15 Dex P8 F 23 23 Pred P9 F 39 10 Pred IVIG P10 M 43 5 None P11 F 64 2 Pred P12 M 29 24 Pred P13 F 71 18 IVIG P14 F 36 4 Pred IVIG P15 M 38 1 Pred P16 F 50 5 None P17 F 42 10 Pred P18 M 54 22 Pred IVIG P19 F 28 3 Pred P20 M 45 33 None P21 F 38 19 None P22 M 42 120 IVIG P23 M 32 170 Dex P24 F 65 105 Pred P25 M 23 150 Dex P26 F 53 130 Pred P27 M 17 190 Dex P28 F 29 100 Pred P29 F 49 140 Pred P30 M 37 120 IVIG P31 F 68 300 Pred P32 F 34 180 Pred * Pred, prednisone; Dex, dexamethasone; Splen,Splenectomy; IVIG, intravenous gamma globulin.</p>

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    3 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us